Trial Profile
Dabigatran and warfarin comparative tolerability and efficacy in a "real-world" setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Sep 2015
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Warfarin
- Indications Embolism and thrombosis; Stroke
- Focus Adverse reactions; Therapeutic Use
- 21 Sep 2015 New trial record
- 15 Sep 2015 Results published in the American Family Physician.